The year in Deals 2023 and beyond Artwork

Next in Health

A weekly healthcare podcast series hosted by PwC's Health Research Institute that addresses industry trends and timely health policy topics impacting patients, providers, payers, pharmaceutical and life sciences companies as well as vendors and new entrants.

All Episodes

Next in Health

The year in Deals 2023 and beyond

August 10, 2023 • PwC's Health Research Institute • Season 4 • Episode 28

Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the deals landscape 2023 and offer a preview of what lies ahead. Topics include:

A look back at M&A activity in health industries so far in 2023
The future of deals: The role of regulators, shareholders, and private equity in the health space
Three areas to keep an eye on: potential legislative or tax changes, stabilization of debt markets and interest rates, and strong data sets

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Igor Belokrinitsky, Strategy& Principal, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.